The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Major Depressive Disorder
Related studies linked through entity extraction aliases.
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061)
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063)
- Status
- COMPLETED
- Phase
- PHASE3
Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress Disorder
- Status
- COMPLETED
- Phase
- N/A
Brain Function in Mentally Ill Adolescents
- Status
- COMPLETED
- Phase
- N/A
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
- Status
- RECRUITING
- Phase
- PHASE2
Treatment for Adolescents With Depression Study (TADS)
- Status
- COMPLETED
- Phase
- PHASE3
Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE4